Literature DB >> 34933897

Long-term reproducibility of optical coherence tomography angiography in healthy and stable glaucomatous eyes.

Takashi Nishida1, Sasan Moghimi1, Huiyuan Hou1, James A Proudfoot1, Aimee C Chang1, Ryan Caezar C David1, Alireza Kamalipour1, Nevin El-Nimri1, Jasmin Rezapour1,2, Christopher Bowd1, Linda M Zangwill1, Robert N Weinreb3.   

Abstract

BACKGROUND/AIMS: To assess and compare long-term reproducibility of optic nerve head (ONH) and macula optical coherence tomography angiography (OCTA) vascular parameters and optical coherence tomography (OCT) thickness parameters in stable primary open-angle glaucoma (POAG), glaucoma suspect and healthy eyes.
METHODS: Eighty-eight eyes (15 healthy, 38 glaucoma suspect and 35 non-progressing POAG) of 68 subjects who had at least three visits within 1-1.5 years with OCTA and OCT imaging (Angiovue; Optovue, Fremont, California, USA) on the same day were included. A series of vascular and thickness parameters were measured including macular parafoveal vessel density (pfVD), ONH circumpapillary capillary density (cpCD), macular parafoveal ganglion cell complex (pfGCC) and ONH circumpapillary retinal nerve fibre layer (cpRNFL). A random effects analysis of variance model was used to estimate intraclass correlation (ICC) coefficients and long-term variability estimates.
RESULTS: ICC was lower for OCTA (pfVD 0.823 (95% CI 0.736 to 0.888) and cpCD 0.871 (0.818 to 0.912)) compared with OCT (pfGCC 0.995 (0.993 to 0.997) and cpRNFL 0.975 (0.964 to 0.984)). Within-subject test-retest SD was 1.17% and 1.22% for pfVD and cpCD, and 0.57 and 1.22 µm for pfGCC and cpRNFL. Older age and lower signal strength index were associated with decreasing long-term variability of vessel densities.
CONCLUSIONS: OCTA-measured macula and ONH vascular parameters have good long-term reproducibility, supporting the use of this instrument for longitudinal analysis. OCTA long-term reproducibility is less than OCT-measured thickness reproducibility. This needs to be taken into consideration when serial OCTA images are evaluated for change. TRIAL REGISTRATION NUMBER: NCT00221897. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  glaucoma; imaging; intraocular pressure; macula

Year:  2021        PMID: 34933897      PMCID: PMC9209558          DOI: 10.1136/bjophthalmol-2021-320034

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   5.908


  33 in total

1.  Long-Term Reproducibility of Macular Ganglion Cell Analysis in Clinically Stable Glaucoma Patients.

Authors:  Ko Eun Kim; Byeong Wook Yoo; Jin Wook Jeoung; Ki Ho Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

2.  Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes.

Authors:  Jean-Claude Mwanza; Robert T Chang; Donald L Budenz; Mary K Durbin; Mohamed G Gendy; Wei Shi; William J Feuer
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

3.  Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma.

Authors:  Liang Liu; Yali Jia; Hana L Takusagawa; Alex D Pechauer; Beth Edmunds; Lorinna Lombardi; Ellen Davis; John C Morrison; David Huang
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

4.  Estimating Optical Coherence Tomography Structural Measurement Floors to Improve Detection of Progression in Advanced Glaucoma.

Authors:  Christopher Bowd; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros; Akram Belghith
Journal:  Am J Ophthalmol       Date:  2016-11-30       Impact factor: 5.258

5.  Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.

Authors:  Xiaolei Wang; Chunhui Jiang; Tony Ko; Xiangmei Kong; Xiaobo Yu; Wang Min; Guohua Shi; Xinghuai Sun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-11       Impact factor: 3.117

6.  Comparison of Short- And Long-Term Variability in Standard Perimetry and Spectral Domain Optical Coherence Tomography in Glaucoma.

Authors:  Carla N Urata; Eduardo B Mariottoni; Alessandro A Jammal; Nara G Ogata; Atalie C Thompson; Samuel I Berchuck; Tais Estrela; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2019-11-09       Impact factor: 5.258

7.  Optical coherence tomography angiography of optic disc perfusion in glaucoma.

Authors:  Yali Jia; Eric Wei; Xiaogang Wang; Xinbo Zhang; John C Morrison; Mansi Parikh; Lori H Lombardi; Devin M Gattey; Rebecca L Armour; Beth Edmunds; Martin F Kraus; James G Fujimoto; David Huang
Journal:  Ophthalmology       Date:  2014-03-12       Impact factor: 12.079

8.  Analysis of Foveal Microvascular Abnormalities in Diabetic Retinopathy Using Optical Coherence Tomography Angiography with Projection Artifact Removal.

Authors:  Lun Liu; Weili Bao; Chengyang Hu; Yajing Xu; Bingying Zhao; Jie Zheng; Lingling Fan; Yehuan Sun
Journal:  J Ophthalmol       Date:  2018-09-18       Impact factor: 1.909

9.  Intrasession repeatability and intersession reproducibility of peripapillary OCTA vessel parameters in non-glaucomatous and glaucomatous eyes.

Authors:  Jae Chang Lee; Dominic J Grisafe; Bruce Burkemper; Brenda R Chang; Xiao Zhou; Zhongdi Chu; Ali Fard; Mary Durbin; Brandon J Wong; Brian J Song; Benjamin Y Xu; Ruikang Wang; Grace M Richter
Journal:  Br J Ophthalmol       Date:  2020-09-11       Impact factor: 4.638

10.  Effect of algorithms and covariates in glaucoma diagnosis with optical coherence tomography angiography.

Authors:  Qi Sheng You; Ou Tan; Shaohua Pi; Liang Liu; Ping Wei; Aiyin Chen; Eliesa Ing; Yali Jia; David Huang
Journal:  Br J Ophthalmol       Date:  2021-06-28       Impact factor: 4.638

View more
  1 in total

Review 1.  The Development and Clinical Application of Innovative Optical Ophthalmic Imaging Techniques.

Authors:  Palaiologos Alexopoulos; Chisom Madu; Gadi Wollstein; Joel S Schuman
Journal:  Front Med (Lausanne)       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.